Keywords: Small Animals, Cell Tracking & Reporter Genes, mesenchymal stem cells, magnetic resonance imaging, bioluminescence imaging, reporter gene, malignant glioma
Motivation: The engraftment status of MSCs in glioma after transplantation via different administration routes remains unclear due to the lack of quantitative analysis.
Goal(s): This study aimed to quantify the engraftment of MSCs in glioma after administration via different routes using noninvasive dual-modality MRI and BLI.
Approach: FTH and FLUC reporter genes-overexpressed MSCs (FTH-FLUC-MSCs) was constructed. MRI and BLI were performed to monitor FTH-FLUC-MSCs in vivo.
Results: Based on quantifying by the optical signal intensity of BLI, peritumoral injection delivered a remarkable proportion of FTH-FLUC-MSCs arrived in the glioma, and a higher quantity of peritumorally injected FTH-FLUC-MSCs retained within the tumor site.
Impact: FTH and FLUC reporter genes-based MRI and BLI are practical tools for noninvasively monitoring the engraftment of MSCs in vivo. Peritumoral delivery of FTH-FLUC-MSCs offers robust engraftment and could be used as the optimal delivery route for treating malignant glioma.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords